| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |